Amrize (NYSE:AMRZ) Coverage Initiated by Analysts at Longbow Research

Longbow Research started coverage on shares of Amrize (NYSE:AMRZ – Free Report) in a report published on Monday morning, Marketbeat reports. The brokerage issued a buy rating on the stock.

AMRZ has been the subject of a number of other reports. Bank of America restated an “underperform” rating and issued a $40.00 target price (down from $50.00) on shares of Amrize in a research note on Wednesday, September 2nd. Weiss Ratings lowered Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday. Stephens dropped their price target on Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 12th. Zacks Research cut Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 19th. Finally, Sanford C. Bernstein reissued an “outperform” rating and issued a $60.00 price target on shares of Amrize in a report on Monday, September 21st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, Amrize has a consensus rating of “Hold” and an average price target of $50.24.

View Our Latest Stock Analysis on Amrize

Amrize Price Performance

Shares of NYSE:AMRZ opened at $36.06 on Monday. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. Amrize has a fifty-two week low of $35.78 and a fifty-two week high of $65.94. The firm has a 50-day simple moving average of $42.03 and a 200 day simple moving average of $49.30. The company has a market cap of $19.95 billion, a PE ratio of 16.62, a P/E/G ratio of 1.27 and a beta of 0.20.

Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). The business had revenue of $3.49 billion for the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. On average, sell-side analysts anticipate that Amrize will post 2.46 EPS for the current year.

Amrize Dividend Announcement

The company also recently declared a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize’s dividend payout ratio is currently 20.28%.

Insider Buying and Selling at Amrize

In other news, Director Jacques Sanche acquired 4,150 shares of the company’s stock in a transaction that occurred on Wednesday, August 26th. The shares were acquired at an average price of $45.02 per share, with a total value of $186,833.00. Following the acquisition, the director directly owned 9,766 shares in the company, valued at approximately $439,665.32. The trade was a 73.90% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Stephen Clark acquired 5,260 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average cost of $47.31 per share, for a total transaction of $248,850.60. Following the acquisition, the insider owned 10,637 shares in the company, valued at approximately $503,236.47. This trade represents a 97.82% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have purchased 48,983 shares of company stock valued at $2,158,755. Corporate insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. National Pension Service raised its stake in shares of Amrize by 7.5% during the second quarter. National Pension Service now owns 1,493,022 shares of the company’s stock valued at $79,578,000 after purchasing an additional 103,962 shares in the last quarter. Ancora Advisors LLC lifted its holdings in Amrize by 22.9% in the second quarter. Ancora Advisors LLC now owns 283,522 shares of the company’s stock worth $15,112,000 after purchasing an additional 52,759 shares during the period. Engle Capital Management L.P. bought a new position in Amrize in the 1st quarter valued at about $3,742,000. Barclays PLC grew its position in Amrize by 95.4% in the 4th quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock valued at $249,557,000 after buying an additional 2,253,431 shares in the last quarter. Finally, Renaissance Technologies LLC grew its position in Amrize by 10.4% in the 1st quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock valued at $109,609,000 after buying an additional 183,900 shares in the last quarter.

About Amrize

(Get Free Report)

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.

See Also

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.